Efficacy of addition of oral simethicone on the quality of bowel preparation for colonoscopy

Efficacy of addition of oral simethicone on the quality of bowel preparation for colonoscopy– a Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068842

Enrollment

224

Registered

2024-06-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: Simethicone with Polyethylene Glycol electrolyte solution: The preparation will be given in split dose. 300 mg of simethicone and 1 litre of PEG-electrolyte solution will be given betwe

Eligibility

Inclusion criteria

Inclusion criteria: Consecutive adult patients aged between 18 and 74 years who were scheduled for diagnostic colonoscopy

Exclusion criteria

Exclusion criteria: Previous history of abdominal surgery Chronic kidney disease with eGFR less than 60ml per min per 1.73m2 Congestive heart failure with New York Heart Association class II to IV Pregnancy or lactation Inflammatory bowel disease Psychiatric illness including diagnosed case of psychosis or schizophrenia or dementia Any patient with suspected lower gastrointestinal bleed

Design outcomes

Primary

Measure	Time frame
Boston Bowel Preparation ScaleTimepoint: Baseline, during colonoscopy	—

Secondary

Measure	Time frame
Bubble score Caecal intubation time Withdrawal time Adverse events Adenoma detection rate Timepoint: Baseline, during colonoscopy	—

Countries

India

Contacts

Public ContactSukrati Maheshwari

Kalinga Institute of Medical Sciences, Bhubaneswar

preetam.nath@kims.ac.in9438870743

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026